INFORMAZIONI SU QUESTO ARTICOLO

Cita

Length of stay, stroke severity and outcomes

Pre-COVID-19 (n=428) COVID-19 (n=441) P value
Episode LOS, days, median (IQR) 4.0 (2-7) 4.7 (3-8) 0.06
Hospital LOS, days, median (IQR) 6.0 (3-10) 6.0 (3.5-10) 0.61
Pre mRS1, median (IQR) 0 (0-2) 0 (0-2) 0.92
NIHSS baseline2, median (IQR) 3 (1-9) 4 (1-11) 0.049
Discharge mRS3, median (IQR) 3 (0-4) 3 (0-4) 0.18
Severe events, n (%) 54 (12.6) 55 (12.5) 0.95
In-hospital Mortality, n (%) 40 (9.3) 55 (12.5) 0.16
Readmission within 28 days, n (%) 32 (7.5) 22 (5.0) 0.16
3 months mRS4, median (IQR) 2 (1-3) 2 (1-3) 0.92

Demographics and key performance measures

Pre-COVID-19 (n=428) COVID-19 (n=441) P value
ED adult presentations 38,576 35,172
Number of stroke code activations, n (%) 742 (1.9) 712 (2.0) 0.33
Diagnosis of stroke / TIA, n (%) 428 (57.7) 441 (61.9) 0.10
Age, median (IQR) 77 (66-86) 77 (67-85) 0.89
Gender, female n (%) 209 (48.8) 225 (51.0) 0.54
Type of stroke diagnosis at discharge, n (%)
    Ischaemic1 295 (68.9) 290 (65.8) 0.32
    Intracranial haemorrhage (ICH) 66 (15.4) 95 (21.5) 0.02
    TIA 67 (15.7) 56 (12.7) 0.21
Known symptom onset, n (%) 235 (54.9) 243 (55.1) 1.00
Time from known onset to ED presentation, minutes median (IQR) 134 (71-251) 134 (77-238) 0.53
ASU or NSICU or NSDU admission2, n (%) 365 (85.3) 378 (85.7) 0.86
Time from ED presentation to ASU or NSICU or NSDU3, minutes median (IQR) 295 (188-555) 260 (183-448) 0.03
Time from presentation to first CT brain imaging4, minutes median (IQR) 32 (19-85) 30 (20-63) 0.57
Reperfusion therapy, ischemic strokes
    IV thrombolysis, n (%) 51 (17.3) 52 (17.9) 0.84
    ECR, n (%) 38 (12.9) 46 (15.9) 0.30
Time from presentation to IVtPA infusion, minutes median (IQR) 60 (43-90) 65 (45-96) 0.53
Time of onset of stroke to IVtPA infusion, minutes median (IQR) 166 (117–218) 186 (136–239) 0.18
eISSN:
2208-6781
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Medicine, Basic Medical Science, other